Nu-Med Plus (NUMD) Total Liabilities (2011 - 2025)
Nu-Med Plus (NUMD) reported Total Liabilities of $279189.0 for Q4 2025, up 24.38% on a YoY basis from $224469.0 in Q4 2024, and up 5.87% sequentially from $263708.0 in Q3 2025.
Nu-Med Plus (NUMD) Total Liabilities (2011 - 2025) Analysis & Trends
Nu-Med Plus (NUMD) has 15 years of Total Liabilities data on file, last reported at $279189.0 in Q4 2025.
- For the quarter ending Q4 2025, Total Liabilities rose 24.38% year-over-year to $279189.0; the trailing twelve-month figure through Dec 2025 stood at $279189.0 (up 24.38% YoY), and the FY2025 full-year result was $279189.0, up 24.38% from the prior year.
- Total Liabilities improved to $279189.0 in Q4 2025, from $263708.0 in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $279189.0 in Q4 2025 to a low of $90781.0 in Q2 2021.
- A 5-year average of $189277.4 and a median of $187249.0 in 2024 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities tumbled 79.4% in 2021 and jumped 181.47% in 2022, its largest moves.
- Tracing NUMD's Total Liabilities over 5 years: stood at $154521.0 in 2021, then decreased by 7.73% to $142570.0 in 2022, then rose by 12.37% to $160207.0 in 2023, then jumped by 40.11% to $224469.0 in 2024, then climbed by 24.38% to $279189.0 in 2025.
- Business Quant data shows NUMD's Total Liabilities at $279189.0 in Q4 2025, $263708.0 in Q3 2025, and $254857.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 23.31 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.99 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.68 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 18.55 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.23 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.17 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | 279,189.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 279,189.00 |
| Sep 30, 2025 | 263,708.00 |
| Jun 30, 2025 | 254,857.00 |
| Mar 31, 2025 | 240,202.00 |
| Dec 31, 2024 | 224,469.00 |
| Sep 30, 2024 | 211,382.00 |
| Jun 30, 2024 | 196,905.00 |
| Mar 31, 2024 | 177,593.00 |
| Dec 31, 2023 | 160,207.00 |
| Sep 30, 2023 | 145,703.00 |
| Jun 30, 2023 | 152,096.00 |
| Mar 31, 2023 | 150,298.00 |
| Dec 31, 2022 | 142,570.00 |
| Sep 30, 2022 | 273,299.00 |
| Jun 30, 2022 | 255,521.00 |
| Mar 31, 2022 | 196,937.00 |
| Dec 31, 2021 | 154,521.00 |
| Sep 30, 2021 | 121,253.00 |
| Jun 30, 2021 | 90,781.00 |
| Mar 31, 2021 | 94,058.00 |